| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 57 |
| 1 | METHOTREXATE | 44 |
| 2 | ROMIDEPSIN | 39 |
| 3 | PREDNISONE | 28 |
| 4 | CYCLOPHOSPHAMIDE | 27 |
| 5 | DOXORUBICIN | 22 |
| 6 | PREDNISOLONE | 22 |
| 7 | PREDNISOLONE ORAL | 22 |
| 8 | BRENTUXIMAB VEDOTIN | 19 |
| 9 | ETANERCEPT | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROMIDEPSIN | 39 | 0.0295 |
| 1 | BRENTUXIMAB VEDOTIN | 19 | 0.0031 |
| 2 | SODIUM HYALURONATE | 1 | 0.0020 |
| 3 | PRALATREXATE | 1 | 0.0019 |
| 4 | GUSELKUMAB | 10 | 0.0008 |
| 5 | FLECAINIDE ACETATE | 3 | 0.0008 |
| 6 | FOSCARNET SODIUM | 2 | 0.0007 |
| 7 | ABACAVIR SULFATE AND LAMIVUDINE | 2 | 0.0006 |
| 8 | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0005 |
| 9 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 19 | 0.0031 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 3 | 0.0011 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | Alkylating Drug [EPC] | 30 | 0.0002 |
| 5 | Antimalarial [EPC] | 1 | 0.0002 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 45 | 0.0001 |
| 7 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 8 | Interleukin-23 Antagonist [EPC] | 12 | 0.0001 |
| 9 | Interleukin-5 Antagonist [EPC] | 3 | 0.0001 |